Explore
Validate
LearnABIN551109
antibody from antibodies-online
Targeting: THRA
AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN551109 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Thyroid Hormone Receptor, alpha (THRA) antibody
- Antibody type
- Polyclonal
- Antigen
- Other
- Description
- Affinity Purified
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mL
Submitted references bcl-2 protein in non-small-cell lung carcinoma.
Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.
Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival.
Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.
Programmed cell death: apoptosis and oncogenesis.
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY
The New England journal of medicine 1993 Sep 2;329(10):690-4
The New England journal of medicine 1993 Sep 2;329(10):690-4
Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC
Cancer research 1993 Oct 1;53(19):4701-14
Cancer research 1993 Oct 1;53(19):4701-14
Structure-function analysis of the Bcl-2 oncoprotein. Addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival.
Tanaka S, Saito K, Reed JC
The Journal of biological chemistry 1993 May 25;268(15):10920-6
The Journal of biological chemistry 1993 May 25;268(15):10920-6
Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.
Pezzella F, Jones M, Ralfkiaer E, Ersbøll J, Gatter KC, Mason DY
British journal of cancer 1992 Jan;65(1):87-9
British journal of cancer 1992 Jan;65(1):87-9
Programmed cell death: apoptosis and oncogenesis.
Williams GT
Cell 1991 Jun 28;65(7):1097-8
Cell 1991 Jun 28;65(7):1097-8
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY
The American journal of pathology 1990 Aug;137(2):225-32
The American journal of pathology 1990 Aug;137(2):225-32
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Image(s): Western Blotting
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Image(s): Immunofluorescence
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Image(s): Immunoprecipitation
